+91 9650760803 
Published: September 9, 2020 | Updated: July 22, 2026
Key Takeaways
- 01. Objective of therapy:
Stem-cell treatment is offered to individuals with Osteomalacia (soft-bone disease) in India, aiming to support bone repair and promote mineralization. - 02. Underlying condition details:
Osteomalacia involves weak or softened bones due to inadequate mineralization, commonly caused by deficiencies in vitamin D, calcium, or phosphate. - 03. Patients’ symptoms and diagnosis:
Symptoms include bone and joint pain (especially in the spine, pelvis, and legs), muscle weakness, walking difficulties, and higher fracture risk. Diagnosis is made through blood tests (vitamin D, calcium, phosphate), imaging, or bone biopsy. - 04. Status and expectations of treatment:
The therapy is said to provide relief and potential improvement in bone strength. However, complete bone healing may take around six months, and a definitive cure is not guaranteed.
What Is Osteomalacia?
Osteomalacia is a condition in which bones fail to mineralize properly, leaving them soft, weak, and prone to bending or fracturing under normal stress. It differs from osteoporosis — where bone density itself is reduced — because in osteomalacia the bone structure (collagen matrix) is present but poorly mineralized, most often due to a shortage of vitamin D, calcium, or phosphate. When this same mineralization defect occurs in growing children, it’s called rickets, and the two conditions frequently overlap in presentation and cause.
Left uncorrected, osteomalacia increases the risk of fractures in weight-bearing bones — the spine, pelvis, hips, and legs — and can cause progressive muscle weakness and difficulty walking. In children, the combination of rickets and osteomalacia can affect bone growth and dental development.
The encouraging part: in the majority of cases, osteomalacia is a correctable deficiency disease. Vitamin D, calcium, or phosphate supplementation — matched to the specific deficiency identified on blood testing — resolves most cases over several months. See Diagnosis for how the underlying cause is confirmed, and Treatment for how standard correction works before any regenerative option is even discussed.
For patients whose osteomalacia is linked to a broader metabolic bone condition, or who have coexisting low bone density, our Osteoporosis and Osteopenia pages cover related — but clinically distinct — conditions where more regenerative-medicine research exists.
What Causes Osteomalacia?
Osteomalacia develops when the body doesn’t get, absorb, or retain enough of the minerals needed for bone mineralization — primarily calcium and phosphate, both of which depend heavily on adequate vitamin D. Common underlying causes include:
- Vitamin D deficiency — the leading global cause. Vitamin D is produced in the skin through sunlight exposure and is essential for calcium absorption; limited sun exposure or a vitamin D-poor diet is the most common root cause worldwide.
- Digestive surgery or malabsorption — procedures that remove or bypass part of the stomach or small intestine can prevent proper absorption of vitamin D and calcium from food.
- Celiac disease — gluten-triggered damage to the small intestine’s lining impairs nutrient absorption, including vitamin D and calcium.
- Kidney or liver disease — both organs are involved in converting vitamin D into its active form; dysfunction in either can block this conversion even when dietary intake is adequate.
- Certain medications — anti-seizure drugs such as phenytoin and phenobarbital are known to interfere with vitamin D metabolism and can contribute to osteomalacia with long-term use.
Why identifying the specific cause matters
Two people with identical symptoms can have completely different underlying causes — one may need only dietary vitamin D correction, while another’s osteomalacia may be a downstream effect of undiagnosed celiac disease or kidney dysfunction that needs its own dedicated treatment. This is why a proper diagnostic work-up (see Diagnosis) always comes before deciding on a treatment path — supplementation alone won’t resolve osteomalacia if an unaddressed absorption or organ-function problem is driving it.
Symptoms of Osteomalacia
Osteomalacia symptoms tend to develop gradually and are easy to mistake for general fatigue or aging-related aches, which is part of why the condition is often under-diagnosed. Common signs include:
- Bone pain or tenderness, especially in the hips, pelvis, lower back, and legs
- Bone fractures occurring without a clear injury, or from minor falls/stress that wouldn’t normally cause a break
- Muscle weakness, particularly affecting the ability to climb stairs or rise from a seated position
- Numbness or tingling around the mouth, and in the arms or legs
- Muscle cramps or twitching, especially in the hands and feet
- A waddling or unsteady gait, in more advanced or longstanding cases
When to see a doctor
If bone pain is persistent, worsening, or accompanied by unexplained fractures or muscle weakness, it warrants a metabolic bone evaluation rather than being dismissed as general soreness — particularly for anyone with limited sun exposure, a restrictive diet, a history of digestive surgery, or a known kidney/liver condition. See Diagnosis for the specific tests used to confirm osteomalacia and rule out related conditions like osteoporosis.
How Is Osteomalacia Diagnosed?
A confirmed osteomalacia diagnosis relies on a combination of blood work and imaging, not symptoms alone:
| Test | What it checks | What confirms osteomalacia |
|---|---|---|
| Blood tests | Calcium, phosphorus, vitamin D, alkaline phosphatase, parathyroid hormone | Low calcium, low phosphorus, low vitamin D, elevated alkaline phosphatase, and elevated parathyroid hormone together support the diagnosis |
| X-ray imaging | Bone structure | Detects Looser’s zones (pseudofractures) — thin, ribbon-like cracks characteristic of osteomalacia |
| Bone biopsy (less common) | Direct tissue mineralization | A small bone tissue sample confirms mineralization defects when blood tests and imaging are inconclusive |
| DEXA scan (used to differentiate) | Bone density | Helps distinguish osteomalacia (mineralization defect) from osteoporosis (density loss) — the two conditions can otherwise look similar on X-ray |
In most cases, blood tests plus X-ray are sufficient to confirm a diagnosis; biopsy is reserved for ambiguous cases. Your evaluating physician will also look for the cause behind the deficiency (see Causes) — for example, screening for celiac disease or kidney function — since treating the root cause is essential to resolving the condition long-term.
If you already have recent blood work and imaging, you can upload your reports for a specialist review rather than repeating tests.
Osteomalacia Treatment: Standard Care First, Regenerative Research Second
The first-line, evidence-backed treatment for osteomalacia is correcting the specific deficiency identified through diagnosis:
- Vitamin D supplementation — dosed according to baseline deficiency severity and rechecked periodically via blood test.
- Calcium and/or phosphate supplementation — where blood work shows a specific mineral shortfall.
- Treating the root cause — for example, a gluten-free diet for celiac-related malabsorption, adjusting medications known to interfere with vitamin D metabolism, or managing an underlying kidney/liver condition.
- Sunlight exposure and dietary guidance — supportive, ongoing measures alongside supplementation. See our Diet Counselling and Nutritional Counseling services for structured support.
- Physiotherapy and supportive rehabilitation — to rebuild muscle strength and mobility as bone mineralization improves. See Physiotherapy.
Most patients see meaningful improvement within a few months of correcting the underlying deficiency, though full bone remineralization can take up to six months to a year depending on severity.
Where does stem cell/regenerative therapy fit in?
Honestly — its role here is limited and should be understood as such. Mesenchymal stem cell (MSC) research relevant to bone health has focused mainly on osteoporosis and general bone-repair models, exploring MSCs’ potential to support osteoblast (bone-building cell) activity. This is adjacent, exploratory research — it has not been established as a validated treatment specifically for osteomalacia, which is fundamentally a deficiency disease rather than a bone-density or structural disorder.
At Viezec, we do not position stem cell therapy as a first-line or primary treatment for osteomalacia. Where a patient’s case involves overlapping bone health concerns — such as coexisting low bone density — our specialists may discuss regenerative options relevant to those specific co-occurring conditions (see Osteoporosis Treatment), always after standard metabolic correction is underway, not instead of it.
For more on how MSC processing works generally, click here
How Mesenchymal Stem Cells Are Sourced and Processed
Where relevant to a patient’s broader bone-health picture, mesenchymal stem cells are most often sourced autologously — from the patient’s own bone marrow or adipose (fat) tissue — or from donor umbilical cord tissue. Cells are isolated and processed under controlled laboratory conditions before administration.
Our processing protocols include donor screening for infectious disease, quality-controlled cell isolation, and documentation of the process for every patient, consistent with our Quality Control standards.
For osteomalacia specifically: this mechanism section is provided for general transparency about how MSC-based approaches work in regenerative medicine broadly. It should not be read as evidence that this mechanism has been clinically validated for osteomalacia — see the note at the top of this document, and the Treatment and Treatment Disclaimer sections for the accurate evidence picture.
For more information on general MSC mechanisms, read here
How Mesenchymal Stem Cells Are Sourced and Processed (General Background)
Where relevant to a patient’s broader bone-health picture, mesenchymal stem cells are most often sourced autologously — from the patient’s own bone marrow or adipose (fat) tissue — or from donor umbilical cord tissue. Cells are isolated and processed under controlled laboratory conditions before administration.
Our processing protocols include donor screening for infectious disease, quality-controlled cell isolation, and documentation of the process for every patient, consistent with our Quality Control standards.
For osteomalacia specifically: this mechanism section is provided for general transparency about how MSC-based approaches work in regenerative medicine broadly. It should not be read as evidence that this mechanism has been clinically validated for osteomalacia — see the note at the top of this document, and the Treatment and Treatment Disclaimer sections for the accurate evidence picture.
For more information on general MSC mechanisms, read here
What Improvement Looks Like in Osteomalacia
Because osteomalacia is a correctable deficiency disease, “improvement” here has a clearer, more measurable definition than in many other conditions we cover — it’s tracked through the same blood markers used for diagnosis:
| Marker | What it shows | Typically rechecked |
|---|---|---|
| Serum vitamin D | Whether supplementation is restoring adequate levels | 2–3 months after starting correction |
| Calcium & phosphate | Mineral availability for bone building | 2–3 months |
| Alkaline phosphatase | Bone turnover activity — should trend down as healing progresses | 3–6 months |
| Parathyroid hormone (PTH) | Whether calcium regulation is normalizing | 3–6 months |
| Follow-up X-ray | Healing of Looser’s zones / pseudofractures | 6–12 months |
What drives real improvement
Improvement in osteomalacia comes overwhelmingly from correcting the underlying deficiency or organ dysfunction — not from a regenerative add-on. If calcium, vitamin D, or phosphate levels aren’t corrected, no cell-based therapy will meaningfully change bone mineralization, because the deficiency itself is the direct cause of the softened bone.
Supportive therapies that genuinely aid recovery during this period include physiotherapy, diet counselling, and occupational therapy — all of which we coordinate as part of a full recovery plan alongside medical correction.
Quick FAQ
Can stem cell therapy alone reverse osteomalacia?
No. Osteomalacia is a mineralization deficiency disease; the evidence-backed path is correcting the specific deficiency (vitamin D, calcium, phosphate) and any underlying cause. Stem cell approaches are not established as a treatment for osteomalacia itself.
How long does recovery typically take?
Blood markers often begin improving within 2–3 months of starting correction; full bone remineralization can take 6–12 months depending on severity and how quickly the underlying cause is addressed.
Does correcting the deficiency fully resolve osteomalacia?
In most cases, yes — provided the root cause (dietary, absorption-related, or organ-related) is also identified and managed, not just the mineral levels alone.
Our Promise
- Deficiency correction comes first, always. We do not propose regenerative options for osteomalacia before a complete metabolic bone work-up and standard nutritional/pharmacological correction plan are in place.
- No overstated claims. We do not market stem cell therapy as a validated cure for osteomalacia — because the current evidence doesn’t support that claim, and saying otherwise wouldn’t serve your health or your trust in us.
- Named, credentialed medical oversight. Every case is reviewed by our specialist team before any treatment plan — regenerative or otherwise — is proposed.
- Accredited facilities. Our facilities hold NABH accreditation and NABL accreditation.
- Regulatory transparency. Where any investigational cell-based approach is discussed as part of a broader bone-health plan, we disclose which regulatory framework in India applies, in writing, before proceeding.
- Location and access. Our facility is based in New Delhi , India — see it on Google Maps.
Treatment Results
What Patients Typically Experience
For patients whose osteomalacia is confirmed and treated through standard deficiency correction, typical reported outcomes include reduced bone pain, improved mobility, fewer muscle cramps, and gradual normalization of blood markers over several months. Patients who also receive supportive therapies — physiotherapy, nutritional counselling — often report faster functional improvement (walking distance, reduced fatigue) than mineral correction alone.
On regenerative/stem cell components specifically: where discussed as part of a broader bone-health plan (typically for patients with coexisting osteoporosis or osteopenia), results are individual and not established as a reliable, quantifiable outcome for osteomalacia itself. We do not publish success percentages for this specific application because the evidence base doesn’t support a defensible number.
For patient result videos across our broader treatment programs, tap here
Testimonials
Ramesh K. – Chennai, India – January 2020 – ⭐⭐⭐⭐☆
“I had constant leg pain from weak bones. After Viezec’s stem cell therapy, my strength improved, and I can walk longer without discomfort.”
Sarah L. – Dublin, Ireland – June 2020 – ⭐⭐⭐⭐⭐
“Osteomalacia left me fatigued and fragile. Post-treatment at Viezec, my bone pain reduced, and I feel healthier and more mobile.”
Omar A. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“My wife had soft bones and frequent aches. After Viezec’s therapy, her strength improved, and she is more confident in daily activities.”
Elena F. – Madrid, Spain – March 2021 – ⭐⭐⭐⭐⭐
“I suffered from bone weakness for years. Stem cell therapy at Viezec restored my energy and reduced the pain in my back and legs.”
Yusuf H. – Istanbul, Turkey – September 2021 – ⭐⭐⭐⭐☆
“Osteomalacia made standing for long periods difficult. Viezec’s treatment gave me stronger bones and a better quality of life.”
Anna K. – Warsaw, Poland – February 2022 – ⭐⭐⭐⭐⭐
“My bones were fragile, and I had frequent fractures. After stem cell therapy, my bone density improved, and I feel safe again.”
Hassan R. – Amman, Jordan – July 2022 – ⭐⭐⭐⭐☆
“My daughter had weak bones due to osteomalacia. Viezec’s therapy gave her better stamina and reduced her bone pain significantly.”
Maria S. – Rome, Italy – April 2023 – ⭐⭐⭐⭐⭐
“Chronic weakness affected my daily life. After treatment at Viezec, my bones feel stronger, and I can enjoy normal routines again.”
Lucas G. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“I was diagnosed with osteomalacia last year. Stem cell therapy helped me regain flexibility and strength, improving my independence.”
Fatima Z. – Nairobi, Kenya – May 2025 – ⭐⭐⭐⭐⭐
“Severe bone pain had limited my lifestyle. Thanks to Viezec’s stem cell therapy, my mobility improved, and I feel active once more.
Frequently Asked Questions
What is stem cell treatment for osteomalacia?
Stem cell treatment for osteomalacia involves using specialized stem cells to support bone regeneration, improve mineralization, and enhance overall bone strength, potentially addressing the root causes of bone softening.
Who is eligible for stem cell therapy for osteomalacia?
Patients with confirmed osteomalacia, especially those with poor response to conventional treatments like vitamin D and calcium supplementation, may be considered after a thorough medical evaluation.
How is stem cell therapy administered for osteomalacia?
Stem cells are usually delivered intravenously or directly into affected bone areas using minimally invasive techniques, under strict clinical supervision to ensure safety and effectiveness.
Is stem cell therapy safe for adults?
When performed in certified clinics by experienced specialists, stem cell therapy is generally safe. Mild side effects may include temporary fatigue, fever, or localized discomfort at the injection site.
How long does it take to see improvements in bone health?
Bone regeneration is gradual, and noticeable improvements in mineral density and bone strength may take several months, depending on patient age, severity of osteomalacia, and overall health.
How many stem cell sessions are typically required?
The number of sessions varies according to individual needs. Most patients undergo 1–3 sessions, with periodic follow-ups to assess bone density and overall response to treatment.
Can stem cell therapy replace vitamin D or calcium supplements?
Stem cell therapy is typically used as a complementary treatment alongside standard therapies like vitamin D and calcium supplementation, rather than a complete replacement.
How can I schedule a consultation for stem cell therapy?
Consultations can be scheduled by contacting our clinic via phone, email, or our online appointment form. Specialists will evaluate your condition and suggest a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Osteomalacia?
The cost of stem cell therapy for osteomalacia varies depending on the underlying cause of the condition, the degree of bone softening, type of stem cells used (autologous or allogenic), number of therapy sessions, and the medical facility’s expertise. Prices also differ from country to country due to variations in healthcare costs and clinical protocols. Below is a general overview of cost ranges across major countries offering this treatment.
Cost Comparison: Select Countries
The table below highlights estimated price ranges shared by clinics and global patients for a complete stem cell therapy program. It typically includes cell extraction and processing, medical evaluation, therapy administration, and post-treatment follow-ups.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $18,000 – $32,000 | ₹14,90,000 – ₹26,40,000 |
| United Kingdom 🇬🇧 | $14,000 – $24,000 | ₹11,60,000 – ₹19,80,000 |
| Germany 🇩🇪 | $16,000 – $26,000 | ₹13,20,000 – ₹21,40,000 |
| Singapore 🇸🇬 | $12,000 – $20,000 | ₹9,90,000 – ₹16,50,000 |
While treatment in Western countries like the USA, UK, or Germany is technologically advanced, the overall costs are significantly higher due to hospital charges, insurance factors, and administrative expenses. In contrast, India provides comparable stem cell therapies at a much lower price without compromising on quality — attracting many international patients seeking regenerative solutions for bone and metabolic disorders such as osteomalacia.
Lower prices in India are mainly due to cost-effective healthcare infrastructure, favorable exchange rates, and efficient clinical operations. Most Indian hospitals use state-of-the-art stem cell labs, internationally trained doctors, and GMP-compliant medical protocols to ensure high treatment standards and safe patient outcomes.
Why Choose Viezec?
Viezec works with certified hospitals and regenerative medicine experts who specialize in treating metabolic bone disorders such as osteomalacia using evidence-based stem cell therapies. We ensure full transparency in cost, ethical medical practices, and continuous patient support throughout your recovery journey.
Get a Personalized Cost Estimate
Each patient’s case is unique. Contact our medical coordinators for a personalized quotation and a detailed treatment roadmap designed for your specific condition.
Treatment Disclaimer
Is stem cell therapy an established treatment for osteomalacia?
No. Osteomalacia is a bone-mineralization disorder caused primarily by vitamin D, calcium, or phosphate deficiency, and the evidence-backed, first-line treatment is correcting that specific deficiency and its underlying cause. Stem cell/regenerative approaches are not established as a validated treatment for osteomalacia specifically, and we do not represent them as such.
What does current evidence actually show?
Mesenchymal stem cell research relevant to bone health exists mainly for osteoporosis and general bone-repair models, much of it in animal studies rather than large human clinical trials. This is adjacent research to osteomalacia, not direct evidence for it. Where we discuss regenerative options in the context of a patient’s broader bone-health picture, we do so as an investigational, exploratory consideration — never as a primary or proven treatment for osteomalacia.
Who is standard treatment intended for, and who might a regenerative discussion be relevant to?
Standard deficiency correction is appropriate for essentially every confirmed osteomalacia case, following diagnostic confirmation. A regenerative-medicine discussion is only relevant where coexisting bone-density loss is also confirmed — and even then, it follows, rather than replaces, standard correction.
Who oversees these decisions?
All treatment plans, standard or investigational, are reviewed by our named treating specialist team following a complete metabolic bone work-up. No protocol — cell-based or otherwise — is proposed without this evaluation.
Where can I get a specific answer for my case?
Book a consultation with our specialist team in New Delhi, and bring your existing blood work and imaging if available, so your evaluation reflects your actual case rather than general information.
Scientific References
The following peer-reviewed studies, clinical reviews, and evidence-based publications provide scientific information regarding the diagnosis, causes, and management of osteomalacia.
Osteomalacia
| Authors | Abdulaziz Alshahrani, Karl G. Alshehri |
| Published | Updated July 3, 2023 |
| Journal | StatPearls Publishing (NCBI Bookshelf) |
| Source | View Publication → |
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets
| Authors | Munns CF, Shaw N, Kiely M, et al. |
| Published | January 2016 |
| Journal | Journal of Clinical Endocrinology & Metabolism |
| Source | View Publication → |
Osteomalacia and Vitamin D Status: A Clinical Update 2017
| Authors | Paul Lips, Natasja M. van Schoor |
| Published | May 2017 |
| Journal | Current Opinion in Endocrinology, Diabetes and Obesity |
| Source | View Publication → |
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline
| Authors | Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. |
| Published | July 2011 |
| Journal | Journal of Clinical Endocrinology & Metabolism |
| Source | View Publication → |
Recognition and Management of Vitamin D Deficiency
| Authors | Michael F. Holick |
| Published | January 2011 |
| Journal | American Family Physician |
| Source | View Publication → |
Vitamin D Deficiency
| Authors | Michael F. Holick |
| Published | September 19, 2013 |
| Journal | New England Journal of Medicine |
| Source | View Publication → |
Conclusion
Stem cell therapy offers a promising approach to managing osteomalacia by promoting bone regeneration and improving mineralization at the cellular level. At Viezec, we combine advanced regenerative medicine techniques with ethical medical standards to provide patients with safe and effective treatment options. Our expert medical team focuses on improving bone strength, reducing pain, and enhancing overall mobility for long-term wellness. With India emerging as a hub for affordable and world-class stem cell therapy, Viezec ensures personalized care and transparent medical guidance every step of the way. To explore how stem cell therapy can help you regain bone health and confidence, connect with our specialists today for a detailed consultation.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
